Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.
Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.
Address: Top Floor, 111 Rathmines Road Lr, Dublin 6
Tel: 353 (01) 441 0024
GreenCross Publishing is owned by Graham Cooke.
You are reading 1 of 2 free-access articles allowed for 30 days
There are currently no authorised clinical trials in Ireland using faecal microbial transplantation (FMT), a spokesperson for the Health Products Regulatory Authority (HPRA) has told this newspaper.
FMT involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent Clostridium difficile infection (CDI).
Last year there were 2,053 notifications of CDI, up from 1,763 in 2017, according to provisional figures released by the Health Protection Surveillance Centre.
In January 2017 the Medical Independent (MI) first reported that the HPRA was considering the regulation of FMT and planned to issue guidance.
In late 2018, the HPRA decided to classify FMT as a medicinal product and said it would accept applications for clinical trials using FMT as an investigational medicinal product. However, no products have received authorisation as yet.
“Following the decision to classify FMT as a medicinal product, the HPRA will accept applications for clinical trials using FMT as an investigational medicinal product,” a spokesperson for the HPRA told MI.
“There are no FMT products with a marketing authorisation at present and there are currently no authorised clinical trials approved in Ireland using FMT.
“In the absence of an authorised product and outside of an approved clinical trial, FMT can be supplied to specialist clinicians as an exempt medicinal product for use by their individual patients under their direct responsibility.”
In 2016, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) classified FMT as a medicinal product, not tissue, thus regulation of FMT changed from the UK Human Tissue Authority to the MHRA.
The HSE has not sought funding from the Department of Health to meet the community service...
The national screening advisory committee (NSAC) is progressing “the development of a methodology...
The ICGP is examining alternative pathways for entry into general practice training as part of efforts...
In December, the HSE released part of an external review into the case of 'Brandon', a...
The evidence on doctor burnout “should scare us and concern us”, the Director of the RCSI...
A review of public health governance structures and addressing “longstanding” IT infrastructure...
Leave a Reply
You must be logged in to post a comment.